Mathew Blackman
Stock Analyst at Stifel
(4.58)
# 263
Out of 4,667 analysts
52
Total ratings
61.29%
Success rate
22.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $18.87 | +27.19% | 4 | Nov 8, 2024 | |
| GMED Globus Medical | Maintains: Buy | $80 → $92 | $83.59 | +10.06% | 4 | Nov 6, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.66 | +80.72% | 1 | Oct 17, 2024 | |
| PEN Penumbra | Initiates: Buy | $238 | $239.20 | -0.50% | 1 | Sep 17, 2024 | |
| NARI Inari Medical | Initiates: Hold | $50 | $49.00 | +2.04% | 1 | Sep 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $75.24 | +32.91% | 11 | Aug 23, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $19 → $16 | $9.93 | +61.13% | 5 | Aug 1, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $55 → $60 | $30.15 | +99.00% | 5 | May 29, 2024 | |
| INGN Inogen | Maintains: Hold | $6 → $7 | $9.46 | -26.00% | 12 | May 8, 2024 | |
| CLPT ClearPoint Neuro | Reiterates: Buy | $8 → $9 | $10.96 | -17.88% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $163 → $208 | $266.58 | -21.97% | 2 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.72 | +13.17% | 4 | May 10, 2023 |
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $18.87
Upside: +27.19%
Globus Medical
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $92
Current: $83.59
Upside: +10.06%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.66
Upside: +80.72%
Penumbra
Sep 17, 2024
Initiates: Buy
Price Target: $238
Current: $239.20
Upside: -0.50%
Inari Medical
Sep 17, 2024
Initiates: Hold
Price Target: $50
Current: $49.00
Upside: +2.04%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $75.24
Upside: +32.91%
Alphatec Holdings
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $9.93
Upside: +61.13%
Tandem Diabetes Care
May 29, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $30.15
Upside: +99.00%
Inogen
May 8, 2024
Maintains: Hold
Price Target: $6 → $7
Current: $9.46
Upside: -26.00%
ClearPoint Neuro
Mar 13, 2024
Reiterates: Buy
Price Target: $8 → $9
Current: $10.96
Upside: -17.88%
Feb 5, 2024
Maintains: Hold
Price Target: $163 → $208
Current: $266.58
Upside: -21.97%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.72
Upside: +13.17%